{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Ocala",
      "state": "FL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "75289",
      "recalling_firm": "Wells Pharmacy Network LLC",
      "address_1": "1210 SW 33rd Ave",
      "address_2": "N/A",
      "postal_code": "34474-2853",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0381-2017",
      "product_description": "NADH/Carnitine/Taurine/B12(M) Injectable, 100 mg/150 mg/150 mg/10 mg, Lyophilized Kit, Compounded by Wells Pharmacy, Ocala, FL",
      "product_quantity": "219 kits (number of vials per kit vary by prescription)",
      "reason_for_recall": "Lack of Assurance of Sterility",
      "recall_initiation_date": "20160921",
      "center_classification_date": "20170104",
      "termination_date": "20210702",
      "report_date": "20170111",
      "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known kit lot code: 04072016@29, 08122016@103.  Known vial lot code: 03302016@13, 03252016@16, 08082016@58, 08082016@67."
    }
  ]
}